Osteoklasty w procesie przebudowy kości

Bone remodeling occurs in three distinct phases: bone resorption, reversal, and formation. During resorption, osteoclasts break down the old bone matrix and release calcium. In the reversal phase, osteoclasts undergo apoptosis and mononuclear phagocytes prepare the site for new bone deposition. Finally, osteoblasts move into the resorption bays and deposit new bone through ossification.

Osteoclasts are multinucleated cells with finger-like projections containing vesicles that secrete enzymes for degrading bone components. These cells cling to bone with ruffled borders and release acid phosphatase, which mineralizes bone by degrading organic collagen and releasing calcium and phosphorus into the bloodstream, creating shallow depressions called resorption bays.

Osteocytes are osteoblasts that become buried in newly formed bone matrix during bone formation. These cells sense mechanical stress on the bone and signal osteoclasts to the remodeling site, initiating the bone resorption phase. This sensing mechanism helps coordinate the bone remodeling process in response to physical demands.

Multiple hormones control bone resorption. Parathyroid hormone increases blood calcium and promotes bone resorption by increasing RANKL activity. Calcitonin, released by the thyroid gland, inhibits bone resorption and promotes formation. Estrogen negatively regulates bone resorption, so estrogen deficiency increases resorption. Growth hormone stimulates both osteoblasts and osteoclasts simultaneously.

After age 40, bone resorption occurs more frequently than formation, reducing bone density. This imbalance results in osteoporosis, making bones weaker and brittle with increased fracture risk. Calcitonin is used therapeutically to treat osteoporosis by inhibiting the resorption process and promoting bone formation through calcium homeostasis.

Osteoclasts originate from hematopoietic progenitor cells in bone marrow. Numerous progenitor cells fuse together to form multinucleated osteoclasts, each containing 10-20 nuclei and measuring 150 to 200 micrometers in diameter. This fusion process creates the large, multinucleated cells necessary for effective bone resorption.

Bone remodeling serves multiple critical functions: repairing minor damage to bone tissue and regulating blood calcium levels for homeostasis. The balance between bone resorption and formation maintains skeletal strength and mineral balance. This continuous remodeling process ensures bones remain structurally sound and calcium availability is maintained for other physiological processes.